Rafferty Asset Management’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-876,332
| Closed | -$3.28M | – | 1077 |
|
|
2023
Q3 | $3.28M | Buy |
+876,332
| New | +$3.28M | 0.02% | 480 |
|
|
2023
Q2 | – | Sell |
-400,569
| Closed | -$2.74M | – | 1100 |
|
|
2023
Q1 | $2.74M | Sell |
400,569
-68,813
| -15% | -$471K | 0.02% | 525 |
|
|
2022
Q4 | $3.72M | Buy |
469,382
+200,546
| +75% | +$1.59M | 0.03% | 440 |
|
|
2022
Q3 | $2.58M | Buy |
268,836
+38,730
| +17% | +$372K | 0.03% | 454 |
|
|
2022
Q2 | $1.67M | Sell |
230,106
-42,181
| -15% | -$305K | 0.02% | 518 |
|
|
2022
Q1 | $3.52M | Buy |
272,287
+90,840
| +50% | +$1.17M | 0.02% | 466 |
|
|
2021
Q4 | $2.9M | Buy |
181,447
+57,458
| +46% | +$917K | 0.02% | 546 |
|
|
2021
Q3 | $1.99M | Sell |
123,989
-55,906
| -31% | -$899K | 0.01% | 636 |
|
|
2021
Q2 | $2.49M | Sell |
179,895
-25,151
| -12% | -$348K | 0.02% | 604 |
|
|
2021
Q1 | $3M | Buy |
205,046
+162,719
| +384% | +$2.38M | 0.02% | 495 |
|
|
2020
Q4 | $736K | Sell |
42,327
-58,629
| -58% | -$1.02M | 0.01% | 594 |
|
|
2020
Q3 | $1.85M | Buy |
100,956
+41,571
| +70% | +$763K | 0.02% | 442 |
|
|
2020
Q2 | $1.06M | Buy |
59,385
+45,524
| +328% | +$813K | 0.01% | 529 |
|
|
2020
Q1 | $225K | Sell |
13,861
-122,540
| -90% | -$1.99M | 0.01% | 497 |
|
|
2019
Q4 | $2.46M | Sell |
136,401
-18,555
| -12% | -$334K | 0.04% | 291 |
|
|
2019
Q3 | $3.14M | Buy |
154,956
+50,800
| +49% | +$1.03M | 0.05% | 222 |
|
|
2019
Q2 | $2.3M | Buy |
104,156
+12,894
| +14% | +$285K | 0.04% | 350 |
|
|
2019
Q1 | $1.25M | Buy |
+91,262
| New | +$1.25M | 0.02% | 506 |
|